Post-approval studies (Phase 4)Looking for participantsNCT05333328
What this trial is testing
OFS in Premenopausal Node+ Breast Cancer With Low Genomic Risk
Who this might be right for
Breast CancerEstrogen Receptor Positive TumorHER2-negative Breast Cancer+2 more
Gangnam Severance Hospital 418